The epigenetic regulation of BRG1 and BRM would allow cancer cells to become quiescent and thereby escape the cytotoxicity of standard chemotherapy as well as maintain their ability to subsequently re-enter the cell cycle. This evidence concerns the gene SMARCA4 and cancer.